ClinicalTrials.gov
ClinicalTrials.gov Menu

Web-based Support for People With Schizophrenia and Their Families

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00177983
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : June 30, 2014
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of Pittsburgh

Brief Summary:
This study will assess the feasibility of using the internet and in-home computers to provide advice from health care professionals, social support, and health information to people with schizophrenia and their families.

Condition or disease Intervention/treatment Phase
Relapse Rates Related to Website Usage Behavioral: (relapse rate) Not Applicable

Detailed Description:

The objective of this study is to assess the feasibility of using the World Wide Web (Web) and in-home computers to provide patients suffering from schizophrenia and their families advice from health care professionals, social support, and information.

The purposes of this intervention are to improve: 1) the availability, convenience and use of needed mental health services; 2) family support for their ill family members; and 3) patient and family outcomes.


Study Type : Interventional  (Clinical Trial)
Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double
Official Title: Support to Patients and Families
Study Start Date : January 2003
Study Completion Date : January 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia




Primary Outcome Measures :
  1. The outcome, patient relapse, will be assessed for the patients in the intervention group and control group by estimating the size of the intervention's effect on relapse rate.

Secondary Outcome Measures :
  1. For the primary caregiver, the distribution of the psychological distress measure will be examined and transformation will be made if necessary for further analysis.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 55 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Diagnosis of schizophrenia Able to speak and read English Regular contact with a family member

Exclusion Criteria:

  • Enrolled in another study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00177983


Locations
United States, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
Sponsors and Collaborators
University of Pittsburgh
National Institute of Mental Health (NIMH)
Investigators
Principal Investigator: Armando J Rotondi, PhD University of Pittsburgh

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT00177983     History of Changes
Other Study ID Numbers: R01MH063484 ( U.S. NIH Grant/Contract )
R01MH063484 ( U.S. NIH Grant/Contract )
First Posted: September 15, 2005    Key Record Dates
Last Update Posted: June 30, 2014
Last Verified: June 2014

Keywords provided by University of Pittsburgh:
Schizophrenia
Relapse
Psychological distress

Additional relevant MeSH terms:
Recurrence
Disease Attributes
Pathologic Processes